Kroger Lubricant Eye Drops (PLD)
- Manufacturer
- The Kroger Co. | Unimed Pharmaceuticals, Inc.
- Effective date
- 2023-12-20
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- full-release
- Hydrated at
- 2026-06-01 00:06:29
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Active ingredient
Carboxymethylcellulose sodium 0.5%
OTC - PURPOSE SECTION
Purpose
Carboxymethylcellulose sodium.............Eye Lubricant
INDICATIONS & USAGE SECTION
Uses
- for the temporary relief of burning, irritation, and discomfort due to dryness of the eye or exposure to wind or sun
- may be used as a protectant against further irritation
WARNINGS SECTION
Warnings
For external use only.
OTC - DO NOT USE SECTION
Do not use if solution changes color or becomes cloudy.
OTC - WHEN USING SECTION
When using the product to avoid contamination
- do not touch tip of container to any surface.
- do not reuse.
- once opened, discard.
- do not touch unit-dose tip to eye.
OTC - STOP USE SECTION
Stop use and ask a doctor if
- you experience eye pain.
- changes in vision occur.
- redness or irritation of the eye continues.
- redness or irritation of the eye worsens or persists for more than 72 hours.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children. If accidentally swallowed, get medical help or contact a Poison Control Center immediately.
DOSAGE & ADMINISTRATION SECTION
Directions
- To open, twist and pull tab to remove.
- Instill 1 or 2 drops in the affected eye(s) as needed and discard container.
- If used for post-operative (e.g., LASIK) dryness and discomfort, follow your eye doctor’s instructions.
OTHER SAFETY INFORMATION
Other information
- Store at 15°-30°C (59°-86°F).
- Use only if single-use container is intact.
- Use before expiration date marked on container.
- RETAIN THIS CARTON FOR FUTURE REFERENCE
INACTIVE INGREDIENT SECTION
Inactive ingredients
Calcium chloride, magnesium chloride, potassium chloride, purified water, sodium
chloride, and sodium lactate. May contain sodium hydroxide and/or hydrochloric acid
to adjust pH.
OTC - QUESTIONS SECTION
Questions or comments?
1-800-632-6900
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | SPL version |
|---|---|---|---|
| 1188426 | carboxymethylcellulose sodium 0.5 % Ophthalmic Solution | PSN | 5 |
| 1188426 | carboxymethylcellulose sodium 5 MG/ML Ophthalmic Solution | SCD | 5 |
| 1188426 | carboxymethylcellulose sodium 0.5 % Ophthalmic Solution | SY | 5 |
| 1188426 | carboxymethylcellulose sodium 0.5 GM per 100 ML Ophthalmic Solution | SY | 5 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 30142-373-33 | Kroger Lubricant Eye | 30 in 1 BOX | SOLUTION/ DROPS | 30 | 5 | |
| 30142-373-33 | Kroger Lubricant Eye | 0.5 mL in 1 VIAL, DISPENSING | SOLUTION/ DROPS | 0.5 | 5 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CARBOXYMETHYLCELLULOSE SODIUM | ACTIVE INGREDIENT | K679OBS311 | 2 | |
| CARBOXYMETHYLCELLULOSE | ACTIVE MOIETY | 05JZI7B19X | 2 | |
| CALCIUM CHLORIDE | INACTIVE INGREDIENT | M4I0D6VV5M | 2 | |
| HYDROCHLORIC ACID | INACTIVE INGREDIENT | QTT17582CB | 2 | |
| MAGNESIUM CHLORIDE | INACTIVE INGREDIENT | 02F3473H9O | 2 | |
| POTASSIUM CHLORIDE | INACTIVE INGREDIENT | 660YQ98I10 | 2 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | 2 | |
| SODIUM HYDROXIDE | INACTIVE INGREDIENT | 55X04QC32I | 2 | |
| SODIUM LACTATE | INACTIVE INGREDIENT | TU7HW0W0QT | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 2 |
Products#
Every source-derived product name is available through these pages.
- Kroger Lubricant Eye
- carboxymethylcellulose sodium
- CALCIUM CHLORIDE
- MAGNESIUM CHLORIDE
- POTASSIUM CHLORIDE
- WATER
- SODIUM CHLORIDE
- SODIUM LACTATE
- SODIUM HYDROXIDE
- HYDROCHLORIC ACID
- CARBOXYMETHYLCELLULOSE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 30142-373 | 30142-373-33 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CALCIUM CHLORIDE | M4I0D6VV5M | IACT |
| MAGNESIUM CHLORIDE | 02F3473H9O | IACT |
| POTASSIUM CHLORIDE | 660YQ98I10 | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM CHLORIDE | 451W47IQ8X | IACT |
| SODIUM LACTATE | TU7HW0W0QT | IACT |
| SODIUM HYDROXIDE | 55X04QC32I | IACT |
| HYDROCHLORIC ACID | QTT17582CB | IACT |
| CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | ACTIB |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | SUSPENSION / ORAL | 20 mg/1ml | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / INTRAPERITONEAL | 0.45 %w/v | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | INJECTION / INTRAVENOUS | 54 mg | ||
| MAGNESIUM CHLORIDE | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / TOPICAL | 0.93 %w/w | ||
| SODIUM CHLORIDE | SODIUM CHLORIDE | 451W47IQ8X | SOLUTION/ DROPS / OPHTHALMIC | 55 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | SUSPENSION / ORAL | 20 mg/1ml | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / TOPICAL | 0.93 %w/w | ||
| CALCIUM CHLORIDE | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | INJECTION, SOLUTION / INFILTRATION | 0.17 %v/v | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | GEL / TOPICAL | 4 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | SOLUTION / INTRAPERITONEAL | 0.45 %w/v | ||
| SODIUM HYDROXIDE | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 18.7 mg | ||
| HYDROCHLORIC ACID | HYDROCHLORIC ACID | QTT17582CB | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| CALCIUM CHLORIDE | CALCIUM CHLORIDE | M4I0D6VV5M | SOLUTION/ DROPS / OPHTHALMIC | 0.02 %w/v | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | INJECTION, SOLUTION / INFILTRATION | 0.17 %v/v | ||
| POTASSIUM CHLORIDE | POTASSIUM CHLORIDE | 660YQ98I10 | SOLUTION/ DROPS / OPHTHALMIC | 0.14 %w/v | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | INJECTION / INTRAVENOUS | 54 mg | ||
| SODIUM LACTATE | SODIUM LACTATE | TU7HW0W0QT | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 18.7 mg | ||
| MAGNESIUM CHLORIDE | MAGNESIUM CHLORIDE | 02F3473H9O | SOLUTION/ DROPS / OPHTHALMIC | 0.03 %w/v |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Kroger Lubricant Eye | CARBOXYMETHYLCELLULOSE SODIUM | The Kroger Co. | 046f4ebc-d8f9-4755-b6ba-790fe86f3128 | 2023-12-20 | Warnings | 30142-373-33 30142-373 30142037333 0cfa7760-7b53-d0b6-e063-6294a90a1fef 046f4ebc-d8f9-4755-b6ba-790fe86f3128 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
